Levitra (Vardenafil) 20mg — Fastest-Onset PDE5 Inhibitor by Dragon Pharma
Levitra (Vardenafil) is Dragon Pharma's formulation of the second-generation PDE5 inhibitor at 20mg per tablet — the fastest-onset of the three primary erectile dysfunction treatments, with a PDE5 binding affinity approximately 3-5× higher than Sildenafil. Vardenafil was developed by Bayer AG and GlaxoSmithKline and received FDA approval in 2003, five years after Sildenafil. Its principal differentiator is pharmacological potency at the PDE5 receptor level: where Sildenafil has an IC50 of approximately 3.5 nM for PDE5, Vardenafil's IC50 is approximately 0.7 nM — meaning it inhibits PDE5 at lower concentrations, translating to faster onset at the 20mg dose and potentially greater efficacy in users where Sildenafil at equivalent dose has proven insufficient.
Also searched as: Levitra 20mg, Vardenafil 20mg, Levitra Dragon Pharma, Vardenafil PDE5, fastest ED pill.
Vardenafil's Higher PDE5 Binding Affinity — What It Means Practically
The IC50 difference between PDE5 inhibitors is a pharmacological detail that competitor content never explains:
- IC50 (half-maximal inhibitory concentration) measures the concentration of a drug needed to inhibit 50% of an enzyme's activity. A lower IC50 means higher potency — the drug achieves the same inhibition at lower blood concentrations
- PDE5 IC50 values across the three primary agents: Vardenafil ~0.7 nM, Sildenafil ~3.5-4 nM, Tadalafil ~0.9 nM. Vardenafil has the highest PDE5 affinity; Sildenafil the lowest of the three
- What this means clinically: Vardenafil achieves PDE5 inhibition at a lower blood concentration threshold — translating to faster onset (meaningful PDE5 inhibition reached sooner after dosing) and potentially greater effect at equivalent oral doses
- This is the mechanistic explanation for Vardenafil's 15-30 minute onset versus Sildenafil's 30-60 minutes — it reaches the PDE5 inhibition threshold in penile tissue faster because the threshold itself is lower
- For users who have found Sildenafil at 50mg insufficient (either slow to onset or inadequate for their degree of ED), Vardenafil at 20mg may provide meaningfully better response due to superior PDE5 affinity
PDE Selectivity Profile — Where Vardenafil Differs From Sildenafil
Each PDE5 inhibitor has a different "off-target" PDE inhibition pattern that explains their different side effect profiles:
- Sildenafil inhibits PDE6 (retinal photoreceptors) at higher doses — producing the blue-tinge visual disturbance that is characteristically associated with Sildenafil above 100mg. Vardenafil has less PDE6 activity — fewer visual side effects
- Tadalafil inhibits PDE11 (testicular and skeletal muscle) — back and muscle aches are a characteristic Tadalafil side effect from PDE11 inhibition in skeletal muscle; PDE11 in testicular tissue is a theoretical concern for fertility with long-term daily use. Vardenafil has minimal PDE11 activity
- Vardenafil has the most selective PDE5 inhibition profile of the three — highest PDE5 affinity with less significant off-target PDE inhibition. This selectivity translates to a characteristically cleaner side effect profile: fewer visual complaints than Sildenafil at comparable dose, fewer muscle/back aches than Tadalafil
- Vardenafil does have some activity at PDE6 but less than Sildenafil; and it has some cardiac PDE effect (QTc prolongation at high doses) — caution in individuals with QT interval prolongation disorders or those taking Class IA or Class III antiarrhythmics
Complete Three-Way PDE5 Inhibitor Comparison
| Parameter | Vardenafil (Levitra) | Sildenafil (Viagra DP) | Tadalafil (Cialis DP) |
|---|---|---|---|
| PDE5 IC50 | ~0.7 nM (highest affinity) | ~3.5–4 nM | ~0.9 nM |
| Onset | 15–30 min (fastest) | 30–60 min | 30–60 min (broader peak) |
| Duration | 4–6 hours | 4–6 hours | 24–36 hours |
| Half-life | ~4–5 hours | ~3–5 hours | ~17.5 hours |
| Food interaction | High-fat meals reduce absorption | High-fat meals delay absorption | No significant interaction |
| PDE6 activity (visual) | Low | Moderate — blue tinge at 100mg | Minimal |
| PDE11 activity (muscle/testicular) | Minimal | Minimal | Moderate — back/muscle ache |
| QTc concern | Yes — avoid with antiarrhythmics | Less | Less |
| Best use case | Fastest reliable onset; Sildenafil non-responders | Standard planned activity | Spontaneous; daily protocol |
When Vardenafil Is the Preferred Choice
Three specific use cases where Vardenafil outperforms the alternatives:
- Maximum onset speed: Where timing precision matters most — events where 15-30 minute onset is significantly more practical than 30-60 minutes. Vardenafil's faster peak is meaningful in contexts where spontaneity is partially desired but specific near-term timing is known
- Sildenafil non-responders: Users who have not achieved adequate response to Sildenafil at 50-100mg — either insufficient effect or acceptable effect requiring 100mg — may respond significantly better to Vardenafil at 20mg due to the superior PDE5 binding affinity. This is pharmacologically not just a "try a different brand" distinction but a meaningful potency step-up
- Minimising visual side effects from Sildenafil: Users who experience blue-tinge visual disturbances with Sildenafil (from PDE6 inhibition) but want equivalent or faster onset — Vardenafil's lower PDE6 activity at its effective PDE5-inhibiting doses produces fewer visual complaints
AAS Context — Vardenafil's Drug Interaction Considerations
A practical consideration specifically relevant to AAS users:
- All three PDE5 inhibitors are primarily metabolised by CYP3A4 — inhibitors of CYP3A4 (certain antibiotics like clarithromycin/erythromycin, antifungals, HIV protease inhibitors) increase PDE5 inhibitor blood levels and risk
- Vardenafil's metabolism is somewhat more sensitive to CYP3A4 inhibition than Sildenafil in some drug interaction studies — meaning co-administration with strong CYP3A4 inhibitors may require more dose reduction with Vardenafil than Sildenafil
- AAS compounds themselves are not significant CYP3A4 inhibitors, so this consideration applies primarily when antibiotics or other CYP3A4 inhibitors are co-administered during a cycle
- Blood pressure management: AAS cycles frequently produce elevated blood pressure; Vardenafil's vasodilation produces blood pressure reduction that may interact with cycle hypertension management — at standard 20mg doses this is manageable, but monitoring is advisable particularly during high-BP AAS cycles
Effects and Benefits
- Fastest onset of available PDE5 inhibitors — 15-30 minutes; pharmacologically explained by highest PDE5 binding affinity
- Highest PDE5 affinity (~0.7 nM IC50) — maximum PDE5 inhibition per milligram of all three agents
- Cleaner PDE6/PDE11 selectivity — fewer visual disturbances than Sildenafil; fewer muscle/back aches than Tadalafil
- FDA-approved — Bayer/GSK development; established clinical safety profile
- Effective for Sildenafil non-responders — the superior PDE5 affinity provides meaningful efficacy advantage
Dosage and Administration
| Dose | Timing | Notes |
|---|---|---|
| 5–10 mg (¼–½ tablet) | 15–30 min before activity | Starting dose; elderly or hepatically impaired users |
| 10 mg (½ tablet) | 15–30 min before activity | Moderate starting dose; well tolerated in most users |
| 20 mg (1 tablet) | 15–30 min before activity | Standard maximum dose; highest efficacy |
Maximum one dose per 24 hours. Take on empty stomach or after a light meal — as with Sildenafil, high-fat meals slow absorption and reduce peak concentration. The 20mg tablet can be split for 10mg or 5mg doses.
Side Effects
- Headache and flushing — from systemic vasodilation; similar to Sildenafil but typically at similar frequency
- Nasal congestion — vasodilation in nasal mucosa
- Visual disturbances — less common than with Sildenafil at equivalent PDE5 inhibition dose; lower PDE6 activity
- Back/muscle ache — much less than Tadalafil; minimal PDE11 activity
- Dyspepsia — GI upset; similar rate to Sildenafil
- QTc prolongation — avoid in QT disorders; relevant for cardiac patients
Related Products
- Sildenafil Viagra DP — original PDE5 inhibitor; 30-60 min onset; standard for planned activity; the reference compound
- Cialis DP (Tadalafil) — longest duration (24-36h); daily low-dose protocol; spontaneous use; PDE5 inhibitor for maximum coverage flexibility
- Cock Bombs — combined Sildenafil + Tadalafil for dual fast-onset and extended duration from one tablet
"Vardenafil's ~0.7 nM PDE5 IC50 — 5× higher affinity than Sildenafil — explains its 15-30 minute onset and effectiveness in Sildenafil non-responders. It achieves therapeutic PDE5 inhibition at lower blood concentrations, faster, with less off-target PDE6 and PDE11 activity than either Sildenafil or Tadalafil."
Storage and Handling
Store Levitra at room temperature, away from direct sunlight and moisture. Keep in original packaging until use.
